W
bioLLM/wiki

AI-Curated Biotech/Medical Knowledge Base
Live
Back to List View Graph View

Hepatitis B

Hepatitis B is a viral infectious disease caused by Hepatitis B virus (HBV), a hepatotropic DNA virus that primarily infects the liver.

Where the papers sit

11 papers from the last 6 months study Hepatitis B directly · updated from PubMed 9 Oct 2026

Study type 1 clinical trial · 8 human data · 2 unclassified

Themes one subject

Those 11 are all about one subject.

  • Hepatitis Prevention and Care

    Hepatitis prevention, clinical management, and diagnostic quality form the common focus. Vaccination work addresses new vaccines, catch-up and life-course policies, schedule safety, coverage measurement, and response in hemodialysis. Clinical studies cover hepatitis B management in people with HIV, autoimmune hepatitis diagnosis, and laboratory verification of infectious markers. The set is broad and policy-oriented, with no single treatment direction or consistent outcome beyond improving prevention and care.

    11 papers

Papers

The 11 papers from the last 6 months that study Hepatitis B directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Hepatitis Prevention and Care (11)
  1. Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany. AIDS (London, England) · 8 Oct 2026 PMID 42847908
  2. Prioritizing the introduction of new vaccine in Tanzania (2026-2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group. Vaccine · 31 Jul 2026 PMID 42537288
  3. Immunogenicity and safety of a 2 + 1 schedule of the DTaP-IPV-HB-Hib hexavalent combination vaccine in preterm infants in Spain. Human vaccines & immunotherapeutics · 26 Jun 2026 PMID 42359964
  4. Assessment of knowledge, attitudes, and behaviors regarding vaccinations among LGBTQIA+ community in Italy. Human vaccines & immunotherapeutics · 25 Jun 2026 PMID 42348835
  5. High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images. Virchows Archiv : an international journal of pathology · 16 Jun 2026 PMID 42301307
  6. Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients. Vaccine · 30 May 2026 PMID 42217446
  7. Global Cancer Prevention: Current Approaches and Future Directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 26 May 2026 PMID 42190157
  8. Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis. Vaccine · 22 May 2026 PMID 42172819
  9. Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. Preventing chronic disease · 22 May 2026 PMID 42170988
  10. Associations between economic crises and childhood vaccination coverage: Evidence from 160 countries, 2000-2019. Global public health · 13 May 2026 PMID 42121307
  11. Establishment of an intelligent auto-verification system for infectious serological markers in a clinical laboratory from West China. Medicine · 1 May 2026 PMID 42065201

By study type

Clinical trials (1)
  1. Immunogenicity and safety of a 2 + 1 schedule of the DTaP-IPV-HB-Hib hexavalent combination vaccine in preterm infants in Spain. Human vaccines & immunotherapeutics · 26 Jun 2026 PMID 42359964
Human data, design not indexed (8)
  1. Prioritizing the introduction of new vaccine in Tanzania (2026-2030): a multi-criteria decision analysis by the Tanzania immunization technical advisory group. Vaccine · 31 Jul 2026 PMID 42537288
  2. Assessment of knowledge, attitudes, and behaviors regarding vaccinations among LGBTQIA+ community in Italy. Human vaccines & immunotherapeutics · 25 Jun 2026 PMID 42348835
  3. Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients. Vaccine · 30 May 2026 PMID 42217446
  4. Global Cancer Prevention: Current Approaches and Future Directions. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 26 May 2026 PMID 42190157
  5. Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis. Vaccine · 22 May 2026 PMID 42172819
  6. Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. Preventing chronic disease · 22 May 2026 PMID 42170988
  7. Associations between economic crises and childhood vaccination coverage: Evidence from 160 countries, 2000-2019. Global public health · 13 May 2026 PMID 42121307
  8. Establishment of an intelligent auto-verification system for infectious serological markers in a clinical laboratory from West China. Medicine · 1 May 2026 PMID 42065201
Unclassified: not yet indexed with MeSH (2)
  1. Adherence to European AIDS clinical society hepatitis B management guidelines in people with HIV: real-world evidence from Spain and Germany. AIDS (London, England) · 8 Oct 2026 PMID 42847908
  2. High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images. Virchows Archiv : an international journal of pathology · 16 Jun 2026 PMID 42301307
bioLLM/wiki is a literature-navigation aid for people who read primary research. It is not a medical resource, and it is not a substitute for a clinician, a pharmacist or the source papers themselves. Because the articles are drafted by language models, they can be incomplete or wrong in ways that read fluently. Please see the editorial policy and medical disclaimer before relying on anything here.

Written from 11 PubMed abstracts, each one listed by PMID above. Published: 2026-07-01. Last written: 2026-08-27 by GPT. Drafted by language models from published abstracts; not medical advice.